There is emerging evidence to support the role of ApoE4 in the vascular dysfunction model of AD, such as reduced cerebral blood flow, endothelial dysfunction, and the breakdown of the blood–brain barrier (BBB). The gene discussed is APOE; the disease is Alzheimer disease.